These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 11060799

  • 1. CTLA4-Ig: a novel immunosuppressive agent.
    Najafian N, Sayegh MH.
    Expert Opin Investig Drugs; 2000 Sep; 9(9):2147-57. PubMed ID: 11060799
    [Abstract] [Full Text] [Related]

  • 2. Blockade of the B7-CD28 pathway by CTLA4-Ig counteracts rejection and prolongs survival in small bowel transplantation.
    Kurlberg G, Haglind E, Schön K, Törnqvist H, Lycke N.
    Scand J Immunol; 2000 Mar; 51(3):224-30. PubMed ID: 10736090
    [Abstract] [Full Text] [Related]

  • 3. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
    Pearson TC, Alexander DZ, Hendrix R, Elwood ET, Linsley PS, Winn KJ, Larsen CP.
    Transplantation; 1996 Apr 15; 61(7):997-1004. PubMed ID: 8623206
    [Abstract] [Full Text] [Related]

  • 4. The role of co-stimulation in airway inflammation.
    Djukanovic R.
    Clin Exp Allergy; 2000 Jun 15; 30 Suppl 1():46-50. PubMed ID: 10849475
    [Abstract] [Full Text] [Related]

  • 5. CD28/B7 costimulation: a review.
    Greenfield EA, Nguyen KA, Kuchroo VK.
    Crit Rev Immunol; 1998 Jun 15; 18(5):389-418. PubMed ID: 9784967
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H, Rathmell JC, Gray GS, Thompson CB, Leiden JM, Alegre ML.
    J Exp Med; 1998 Jul 06; 188(1):199-204. PubMed ID: 9653096
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of corneal allograft reaction by CTLA4-Ig.
    Hoffmann F, Zhang EP, Pohl T, Kunzendorf U, Wachtlin J, Bulfone-Paus S.
    Graefes Arch Clin Exp Ophthalmol; 1997 Aug 06; 235(8):535-40. PubMed ID: 9285225
    [Abstract] [Full Text] [Related]

  • 8. Protection of corneal allografts by CTLA4-Ig.
    Gebhardt BM, Hodkin M, Varnell ED, Kaufman HE.
    Cornea; 1999 May 06; 18(3):314-20. PubMed ID: 10336035
    [Abstract] [Full Text] [Related]

  • 9. Transplantation and the CD28/CTLA4/B7 pathway.
    Alegre M, Fallarino F, Zhou P, Frauwirth K, Thistlethwaite J, Newell K, Gajewski T, Bluestone J.
    Transplant Proc; 2001 May 06; 33(1-2):209-11. PubMed ID: 11266782
    [No Abstract] [Full Text] [Related]

  • 10. Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig.
    Knoerzer DB, Karr RW, Schwartz BD, Mengle-Gaw LJ.
    J Clin Invest; 1995 Aug 06; 96(2):987-93. PubMed ID: 7543497
    [Abstract] [Full Text] [Related]

  • 11. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P.
    Transplantation; 1996 Oct 15; 62(7):1011-8. PubMed ID: 8878397
    [Abstract] [Full Text] [Related]

  • 12. CD28-specific antibody prevents graft-versus-host disease in mice.
    Yu XZ, Bidwell SJ, Martin PJ, Anasetti C.
    J Immunol; 2000 May 01; 164(9):4564-8. PubMed ID: 10779758
    [Abstract] [Full Text] [Related]

  • 13. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.
    Dengler TJ, Szabo G, Sido B, Nottmeyer W, Zimmerman R, Vahl CF, Hünig T, Meuer SC.
    Transplantation; 1999 Feb 15; 67(3):392-8. PubMed ID: 10030284
    [Abstract] [Full Text] [Related]

  • 14. Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses.
    Comoli P, Locatelli F, Moretta A, Montagna D, Calcaterra V, Cometa A, Basso S, Zecca M, Maccario R.
    Bone Marrow Transplant; 2001 Jun 15; 27(12):1263-73. PubMed ID: 11548844
    [Abstract] [Full Text] [Related]

  • 15. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice.
    Blazar BR, Taylor PA, Linsley PS, Vallera DA.
    Blood; 1994 Jun 15; 83(12):3815-25. PubMed ID: 7515723
    [Abstract] [Full Text] [Related]

  • 16. Immunomodulation with CTLA4-Ig in islet transplantation.
    Benhamou PY.
    Transplantation; 2002 Jan 15; 73(1 Suppl):S40-2. PubMed ID: 11810061
    [Abstract] [Full Text] [Related]

  • 17. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7.
    Vaughan AN, Malde P, Rogers NJ, Jackson IM, Lechler RI, Dorling A.
    J Immunol; 2000 Sep 15; 165(6):3175-81. PubMed ID: 10975832
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of targeting CD28 by a signaling monoclonal antibody in acute and chronic allograft rejection.
    Dong VM, Yuan X, Coito AJ, Waaga AM, Sayegh MH, Chandraker A.
    Transplantation; 2002 Apr 27; 73(8):1310-7. PubMed ID: 11981427
    [Abstract] [Full Text] [Related]

  • 19. CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis.
    Reynolds J, Tam FW, Chandraker A, Smith J, Karkar AM, Cross J, Peach R, Sayegh MH, Pusey CD.
    J Clin Invest; 2000 Mar 27; 105(5):643-51. PubMed ID: 10712436
    [Abstract] [Full Text] [Related]

  • 20. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
    Daikh D, Wofsy D, Imboden JB.
    J Leukoc Biol; 1997 Aug 27; 62(2):156-62. PubMed ID: 9261329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.